Randomized Controlled Clinical Trial of Cinnamon to Lower Hemoglobin A1c
A Randomized Controlled Clinical Trial Comparing the Effect of 1g of Daily Cinnamon Plus Usual Care to Usual Cre on the Hemoglobin A1c of Uncontrolled Type 2 Diabetics
1 other identifier
interventional
109
1 country
1
Brief Summary
This study will randomize diabetics with hemoglobin A1c greater than 7.0 to receive either cinnamon plus usual care or usual care alone. Hemoglobin A1c will be measured at intake and after 90 days.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3 diabetes
Started Mar 2007
Shorter than P25 for phase_3 diabetes
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2007
CompletedFirst Submitted
Initial submission to the registry
March 7, 2007
CompletedFirst Posted
Study publicly available on registry
March 9, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2007
CompletedFebruary 7, 2019
February 1, 2019
5 months
March 7, 2007
February 6, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
hemoglobin A1c
Secondary Outcomes (1)
diabetes medications
Interventions
Eligibility Criteria
You may qualify if:
- Type 2 diabetics greater tahn 18 years of age
You may not qualify if:
- allergy to cinnamon pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Eglin AFB Regional Hospital
Eglin Air Force Base, Florida, 32542, United States
Related Publications (5)
Talpur N, Echard B, Ingram C, Bagchi D, Preuss H. Effects of a novel formulation of essential oils on glucose-insulin metabolism in diabetic and hypertensive rats: a pilot study. Diabetes Obes Metab. 2005 Mar;7(2):193-9. doi: 10.1111/j.1463-1326.2004.00386.x.
PMID: 15715893BACKGROUNDKhan A, Safdar M, Ali Khan MM, Khattak KN, Anderson RA. Cinnamon improves glucose and lipids of people with type 2 diabetes. Diabetes Care. 2003 Dec;26(12):3215-8. doi: 10.2337/diacare.26.12.3215.
PMID: 14633804BACKGROUNDVanschoonbeek K, Thomassen BJ, Senden JM, Wodzig WK, van Loon LJ. Cinnamon supplementation does not improve glycemic control in postmenopausal type 2 diabetes patients. J Nutr. 2006 Apr;136(4):977-80. doi: 10.1093/jn/136.4.977.
PMID: 16549460BACKGROUNDMang B, Wolters M, Schmitt B, Kelb K, Lichtinghagen R, Stichtenoth DO, Hahn A. Effects of a cinnamon extract on plasma glucose, HbA, and serum lipids in diabetes mellitus type 2. Eur J Clin Invest. 2006 May;36(5):340-4. doi: 10.1111/j.1365-2362.2006.01629.x.
PMID: 16634838BACKGROUNDCrawford P. Effectiveness of cinnamon for lowering hemoglobin A1C in patients with type 2 diabetes: a randomized, controlled trial. J Am Board Fam Med. 2009 Sep-Oct;22(5):507-12. doi: 10.3122/jabfm.2009.05.080093.
PMID: 19734396DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Paul F Crawford, MD
Eglin AFB Hospital
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
Study Record Dates
First Submitted
March 7, 2007
First Posted
March 9, 2007
Study Start
March 1, 2007
Primary Completion
August 1, 2007
Study Completion
August 1, 2007
Last Updated
February 7, 2019
Record last verified: 2019-02